Top Markets
#1 pippin pippin +16.86%
#2 Aria.AI Aria.AI +14.74%
#3 River Pts River Pts +14.68%
#4 Janction Janction +13.50%
#5 Strategic Oil Supply Strategic Oil Supply +12.21%
#6 TRIA TRIA +12.05%
#7 DeXe DeXe +11.31%
#8 Osaka Protocol Osaka Protocol +10.09%
#9 Lava Network Lava Network +8.51%
#10 Orochi Network Orochi Network +8.44%
Coin of the day
pippin pippin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Clasificación en acciones #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Precio por acción
$37.45
Capitalización bursátil
$166.43B
Cambio (1 día)
-2.55%
Cambio (1 año)
-53.09%
País
DK
Comercio Novo Nordisk A/S (NVO)

Categoría

Healthcare
Ganancias de Novo Nordisk A/S (NVO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Novo Nordisk A/S, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Novo Nordisk A/S desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.45B -
NL